Nutrinia

Drug products to treat acute to chronic intestinal failure based on its proprietary Oral Insulin technology

placeRamat Gan, Tel Aviv District, Israel calendar_todayFounded 2003 groups3 employees language nutrinia.com

Innovation

11 patent families (6 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 562 times.

YearFilings
20123
20133
20142
20156
20162
20175
20183
20192
20202
20212
20231

Investor mix

8 investors on record; lead investors include TPG.

Investor typeCountShare
Venture capital338%
Private equity225%
Other / undisclosed338%
Coming soon